Selected research
Industry Research
Salbutamol Industry Research Report 2026
Market perspective
The global Salbutamol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Salbutamol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Salbutamol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Salbutamol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Salbutamol include Teva Pharmaceuticals, Mylan, GlaxoSmithKline, Novex, Armstrong Pharmaceuticals, Apotex and 3M Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Salbutamol market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Salbutamol Market by Company
Teva Pharmaceuticals
Mylan
GlaxoSmithKline
Novex
Armstrong Pharmaceuticals
Apotex
3M Pharmaceuticals Inc
Salbutamol Segment by Type
Aerosol
Aerosol, Spray
Solution
Inhalant
Salbutamol Segment by Application
Human
Animal
Salbutamol Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Salbutamol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Salbutamol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Salbutamol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Salbutamol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Salbutamol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Salbutamol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aerosol
- Aerosol, Spray
- Solution
- Inhalant
Applications
- Human
- Animal
Companies covered
- Teva Pharmaceuticals
- Mylan
- GlaxoSmithKline
- Novex
- Armstrong Pharmaceuticals
- Apotex
- 3M Pharmaceuticals Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Salbutamol Market Size (2021-2032)
- 2.2.2 Global Salbutamol Sales (2021-2032)
- 2.2.3 Global Salbutamol Market Average Price (2021-2032)
- 2.3 Salbutamol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aerosol
- 2.3.3 Aerosol, Spray
- 2.3.4 Solution
- 2.3.5 Inhalant
- 2.4 Salbutamol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Animal
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Salbutamol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Salbutamol Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Salbutamol Revenue of Manufacturers (2021-2026)
- 3.4 Global Salbutamol Average Price by Manufacturers (2021-2026)
- 3.5 Global Salbutamol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Salbutamol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Salbutamol, Product Type & Application
- 3.8 Global Manufacturers of Salbutamol, Established Date
- 3.9 Global Salbutamol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals
- 4.1.1 Teva Pharmaceuticals Company Information
- 4.1.2 Teva Pharmaceuticals Business Overview
- 4.1.3 Teva Pharmaceuticals Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals Salbutamol Product Portfolio
- 4.1.5 Teva Pharmaceuticals Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Salbutamol Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 GlaxoSmithKline
- 4.3.1 GlaxoSmithKline Company Information
- 4.3.2 GlaxoSmithKline Business Overview
- 4.3.3 GlaxoSmithKline Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GlaxoSmithKline Salbutamol Product Portfolio
- 4.3.5 GlaxoSmithKline Recent Developments
- 4.4 Novex
- 4.4.1 Novex Company Information
- 4.4.2 Novex Business Overview
- 4.4.3 Novex Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novex Salbutamol Product Portfolio
- 4.4.5 Novex Recent Developments
- 4.5 Armstrong Pharmaceuticals
- 4.5.1 Armstrong Pharmaceuticals Company Information
- 4.5.2 Armstrong Pharmaceuticals Business Overview
- 4.5.3 Armstrong Pharmaceuticals Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Armstrong Pharmaceuticals Salbutamol Product Portfolio
- 4.5.5 Armstrong Pharmaceuticals Recent Developments
- 4.6 Apotex
- 4.6.1 Apotex Company Information
- 4.6.2 Apotex Business Overview
- 4.6.3 Apotex Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Apotex Salbutamol Product Portfolio
- 4.6.5 Apotex Recent Developments
- 4.7 3M Pharmaceuticals Inc
- 4.7.1 3M Pharmaceuticals Inc Company Information
- 4.7.2 3M Pharmaceuticals Inc Business Overview
- 4.7.3 3M Pharmaceuticals Inc Salbutamol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 3M Pharmaceuticals Inc Salbutamol Product Portfolio
- 4.7.5 3M Pharmaceuticals Inc Recent Developments
5 Global Salbutamol Market Scenario by Region
- 5.1 Global Salbutamol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Salbutamol Sales by Region: 2021-2032
- 5.2.1 Global Salbutamol Sales by Region: 2021-2026
- 5.2.2 Global Salbutamol Sales by Region: 2027-2032
- 5.3 Global Salbutamol Revenue by Region: 2021-2032
- 5.3.1 Global Salbutamol Revenue by Region: 2021-2026
- 5.3.2 Global Salbutamol Revenue by Region: 2027-2032
- 5.4 North America Salbutamol Market Facts & Figures by Country
- 5.4.1 North America Salbutamol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Salbutamol Sales by Country (2021-2032)
- 5.4.3 North America Salbutamol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Salbutamol Market Facts & Figures by Country
- 5.5.1 Europe Salbutamol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Salbutamol Sales by Country (2021-2032)
- 5.5.3 Europe Salbutamol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Salbutamol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Salbutamol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Salbutamol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Salbutamol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Salbutamol Market Facts & Figures by Country
- 5.7.1 South America Salbutamol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Salbutamol Sales by Country (2021-2032)
- 5.7.3 South America Salbutamol Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Salbutamol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Salbutamol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Salbutamol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Salbutamol Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Salbutamol Sales by Type (2021-2032)
- 6.1.1 Global Salbutamol Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Salbutamol Sales Market Share by Type (2021-2032)
- 6.2 Global Salbutamol Revenue by Type (2021-2032)
- 6.2.1 Global Salbutamol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Salbutamol Revenue Market Share by Type (2021-2032)
- 6.3 Global Salbutamol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Salbutamol Sales by Application (2021-2032)
- 7.1.1 Global Salbutamol Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Salbutamol Sales Market Share by Application (2021-2032)
- 7.2 Global Salbutamol Revenue by Application (2021-2032)
- 7.2.1 Global Salbutamol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Salbutamol Revenue Market Share by Application (2021-2032)
- 7.3 Global Salbutamol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Salbutamol Value Chain Analysis
- 8.1.1 Salbutamol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Salbutamol Production Mode & Process
- 8.2 Salbutamol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Salbutamol Distributors
- 8.2.3 Salbutamol Customers
9 Global Salbutamol Analyzing Market Dynamics
- 9.1 Salbutamol Industry Trends
- 9.2 Salbutamol Industry Drivers
- 9.3 Salbutamol Industry Opportunities and Challenges
- 9.4 Salbutamol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst